FierceBiotech3h
Journey of Voyager’s ALS gene therapy to clinic hindered by need to find alternative payload
The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...
Science Daily3d
ALS survival may be cut short by living in disadvantaged communities
Living in a disadvantaged community may decrease the length of time a person can survive with amyotrophic lateral sclerosis, or ALS, by over 30%, a study suggests. Similar studies have shown that ...
Voyager Therapeutics to Assess 'Alternative Payloads' for ALS Gene Therapy Program
Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.
ALS News Today1d
US trial of noninvasive ALS device gets green light to enroll patients
A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...
ALS News Today5d
Repeated brain injury quickens ALS onset and progression in mice
Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...